Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

Steven Darryll Heys; A. W. Hutcheon; T. K. Sarkar; Keith Nicholas Ogston; Iain D Miller; S. Payne; I. Smith; L. G. Walker; O. Eremin

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

Steven Darryll Heys, A. W. Hutcheon, T. K. Sarkar, Keith Nicholas Ogston, Iain D Miller, S. Payne, I. Smith, L. G. Walker, O. Eremin

Research output: Contribution to journal › Article › peer-review

161 Citations (Scopus)

Original language	English
Pages (from-to)	S69-74
Journal	Clinical Breast Cancer
Volume	3
Issue number	Suppl 2
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{8cd261dc0b894e90b1865e7065f33e70,

title = "Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial",

author = "Heys, {Steven Darryll} and Hutcheon, {A. W.} and Sarkar, {T. K.} and Ogston, {Keith Nicholas} and Miller, {Iain D} and S. Payne and I. Smith and Walker, {L. G.} and O. Eremin",

year = "2002",

language = "English",

volume = "3",

pages = "S69--74",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "Suppl 2",

}

TY - JOUR

T1 - Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

AU - Heys, Steven Darryll

AU - Hutcheon, A. W.

AU - Sarkar, T. K.

AU - Ogston, Keith Nicholas

AU - Miller, Iain D

AU - Payne, S.

AU - Smith, I.

AU - Walker, L. G.

AU - Eremin, O.

PY - 2002

Y1 - 2002

M3 - Article

VL - 3

SP - S69-74

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - Suppl 2

ER -